TRINITY BIOTECH PLC (TRIB) Operating margin 2015–2024
TRINITY BIOTECH PLC (TRIB) operating margin by fiscal year — reported operating income divided by reported revenue.
-34.4%FY2024 · since FY2015: 13.5% → -34.4%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | -34.4% | +13.2 pp |
| FY2023 | -47.6% | -16.6 pp |
| FY2022 | -30.9% | -35.8 pp |
| FY2021 | 4.9% | +4.8 pp |
| FY2020 | 0.1% | +26.7 pp |
| FY2019 | -26.7% | -5.8 pp |
| FY2018 | -20.8% | +17.1 pp |
| FY2017 | -38.0% | +2.0 pp |
| FY2016 | -40.0% | -53.5 pp |
| FY2015 | 13.5% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More TRIB financial trends
TRIB RevenueTRIB Net incomeTRIB Net marginTRIB Gross profitTRIB Gross marginTRIB Operating incomeTRIB Operating cash flowTRIB Free cash flowTRIB Capital expendituresTRIB Return on equityTRIB Stock buybacksTRIB Dividends paidTRIB Total assetsTRIB Total liabilitiesTRIB Shareholders’ equityTRIB overview →